We highlight tumor antigen essentiality and the sustainment of memory T cell responses as two remaining barriers and offer a framework for addressing them via mRNA vaccines that target antigens that are essential for tumor cell survival and co-encode T cell memory and survival signals, including IL-7. Here, IL7 is linked to neoplasm.